MENU
BRNS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Barinthus Biotherapeutics (BRNS) Ownership - Who owns Barinthus Biotherapeutics?
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer... Show more
Profile
Industry
N/A
Address
Unit 6-10, Rutherford Avenue
Phone
+44 1865818808
Employees
98
Web
https://www.barinthusbio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
29.44M
P/E Ratio
N/A
Total Cash
110.66M
Projected Growth
N/A
Total Debt
12.01M
Revenue
14.97M
Risk (Beta)
-0.91
Dividend Yield
N/A
Total Cash/Share
2.74
Total Debt/Equity
N/A
Revenue/Share
0.38 USD as % of share price
Fundamentals
BRNS
Capitalization
29.4M
P/E Ratio
N/A
Risk (Beta)
-0.91
Dividend Yield
N/A
Total Cash
111M
Total Cash/Share
2.74
Total Debt
12M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.38%
Revenue
15M
ROE
N/A
Book Value
130M
P/B Ratio
0.23
Cash Flow
N/A
Earnings
-1.55
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1K
Current Ratio
8.03
Current Revenue Per Employee
115146.16
Dividends Per Share - Security
N/A
EBITDA
-55.37M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-32.59
Shares Held By Institutions
9.72M
Shares Outstanding - Current
40.3M
Total Liabilities
30.2M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-39.578
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Unit 6-10, Rutherford Avenue
Phone
+44 1865818808
Employees
98
Web
https://www.barinthusbio.com